Hanley Jr. Michael Conick (CIK 0001791413)

Latest company ownership

SYRE - Spyre Therapeutics, Inc.
Role: Chief Commercial Officer
Shares held
36,200
Last filed at
Jun 10, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 8, 2022 Jun 10, 2022 Spyre Therapeutics, Inc. Chief Commercial Officer Buy 91.3 +28,200 352.50% ✗ $20K